Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging Expertise.

Nass SJ, Cogle CR, Brink JA, Langlotz CP, Balogh EP, Muellner A, Siegal D, Schilsky RL, Hricak H.

J Clin Oncol. 2019 May 3:JCO1801970. doi: 10.1200/JCO.18.01970. [Epub ahead of print] No abstract available.

PMID:
31050908
2.

Accelerating anticancer drug development - opportunities and trade-offs.

Nass SJ, Rothenberg ML, Pentz R, Hricak H, Abernethy A, Anderson K, Gee AW, Harvey RD, Piantadosi S, Bertagnolli MM, Schrag D, Schilsky RL.

Nat Rev Clin Oncol. 2018 Dec;15(12):777-786. doi: 10.1038/s41571-018-0102-3. Review.

PMID:
30275514
3.

Weight management and physical activity throughout the cancer care continuum.

Demark-Wahnefried W, Schmitz KH, Alfano CM, Bail JR, Goodwin PJ, Thomson CA, Bradley DW, Courneya KS, Befort CA, Denlinger CS, Ligibel JA, Dietz WH, Stolley MR, Irwin ML, Bamman MM, Apovian CM, Pinto BM, Wolin KY, Ballard RM, Dannenberg AJ, Eakin EG, Longjohn MM, Raffa SD, Adams-Campbell LL, Buzaglo JS, Nass SJ, Massetti GM, Balogh EP, Kraft ES, Parekh AK, Sanghavi DM, Morris GS, Basen-Engquist K.

CA Cancer J Clin. 2018 Jan;68(1):64-89. doi: 10.3322/caac.21441. Epub 2017 Nov 22. Review. Erratum in: CA Cancer J Clin. 2018 May;68(3):232.

4.

Commentary on the Consensus Statement of the American Society of Breast Surgeons on Contralateral Prophylactic Mastectomy.

Nass SJ, Nekhlyudov L.

Ann Surg Oncol. 2017 Mar;24(3):611-613. doi: 10.1245/s10434-016-5758-2. Epub 2017 Jan 5.

PMID:
28058555
5.

Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop.

Nass SJ, Beaupin LK, Demark-Wahnefried W, Fasciano K, Ganz PA, Hayes-Lattin B, Hudson MM, Nevidjon B, Oeffinger KC, Rechis R, Richardson LC, Seibel NL, Smith AW.

Oncologist. 2015 Feb;20(2):186-95. doi: 10.1634/theoncologist.2014-0265. Epub 2015 Jan 7. Review.

6.
7.

Reducing tobacco-related cancer incidence and mortality: summary of an institute of medicine workshop.

Balogh EP, Dresler C, Fleury ME, Gritz ER, Kean TJ, Myers ML, Nass SJ, Nevidjon B, Toll BA, Warren GW, Herbst RS.

Oncologist. 2014 Jan;19(1):21-31. doi: 10.1634/theoncologist.2013-0230. Epub 2013 Dec 4.

8.

Practice-Changing Strategies to Deliver Affordable, High-Quality Cancer Care: Summary of an Institute of Medicine Workshop.

Balogh EP, Bach PB, Eisenberg PD, Ganz PA, Green RJ, Gruman JC, Nass SJ, Newcomer LN, Ramsey SD, Schottinger JE, Shih YT.

J Oncol Pract. 2013 Nov;9(6S):54s-59s. doi: 10.1200/JOP.2013.001123.

PMID:
29431037
9.

Accelerating cancer therapy development: the importance of combination strategies and collaboration. Summary of an Institute of Medicine workshop.

LoRusso PM, Canetta R, Wagner JA, Balogh EP, Nass SJ, Boerner SA, Hohneker J.

Clin Cancer Res. 2012 Nov 15;18(22):6101-9. doi: 10.1158/1078-0432.CCR-12-2455. Epub 2012 Oct 12.

10.

Patient-centered cancer treatment planning: improving the quality of oncology care. Summary of an Institute of Medicine workshop.

Balogh EP, Ganz PA, Murphy SB, Nass SJ, Ferrell BR, Stovall E.

Oncologist. 2011;16(12):1800-5. doi: 10.1634/theoncologist.2011-0252. Epub 2011 Nov 29.

11.

National Cancer Policy Summit: addressing opportunities and challenges in cancer care and research.

Nass SJ, Balogh E.

Clin Pharmacol Ther. 2011 Jun;89(6):770-1. doi: 10.1038/clpt.2011.64. Epub 2011 Apr 20. No abstract available.

PMID:
21508936
12.

A National Cancer Clinical Trials Network: recommendations from the Institute of Medicine.

Nass SJ, Balogh E, Mendelsohn J.

Am J Ther. 2011 Sep;18(5):382-91. doi: 10.1097/MJT.0b013e3181ff7e23.

13.

Opening up to precompetitive collaboration.

Altshuler JS, Balogh E, Barker AD, Eck SL, Friend SH, Ginsburg GS, Herbst RS, Nass SJ, Streeter CM, Wagner JA.

Sci Transl Med. 2010 Oct 6;2(52):52cm26. doi: 10.1126/scitranslmed.3001515.

PMID:
20926831
14.

Strategies to facilitate the development of new contraceptives.

Nass SJ, Strauss JF 3rd.

Nat Rev Drug Discov. 2004 Oct;3(10):885-90. Review.

PMID:
15459679
15.

Research on contraceptives.

Nass SJ, Strauss JF 3rd.

Science. 2004 Mar 19;303(5665):1769-71. No abstract available.

PMID:
15031479
16.

Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.

Yan L, Nass SJ, Smith D, Nelson WG, Herman JG, Davidson NE.

Cancer Biol Ther. 2003 Sep-Oct;2(5):552-6.

PMID:
14614325
17.

Mammography to molecular biology: opportunities and obstacles in developing early breast cancer detection methods.

Nass SJ.

Oncol Nurs Forum. 2002 Jan-Feb;29(1):21-2. No abstract available.

PMID:
11817488
18.

Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.

Yang X, Ferguson AT, Nass SJ, Phillips DL, Butash KA, Wang SM, Herman JG, Davidson NE.

Cancer Res. 2000 Dec 15;60(24):6890-4.

19.

C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance.

Deming SL, Nass SJ, Dickson RB, Trock BJ.

Br J Cancer. 2000 Dec;83(12):1688-95.

20.

Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.

Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE, Graff JR.

Cancer Res. 2000 Aug 15;60(16):4346-8.

21.

The loss of estrogen and progesterone receptor gene expression in human breast cancer.

Lapidus RG, Nass SJ, Davidson NE.

J Mammary Gland Biol Neoplasia. 1998 Jan;3(1):85-94. Review.

PMID:
10819507
22.

Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells.

Nass SJ, Ferguson AT, El-Ashry D, Nelson WG, Davidson NE.

Oncogene. 1999 Dec 9;18(52):7453-61.

23.

The biology of breast cancer.

Nass SJ, Davidson NE.

Hematol Oncol Clin North Am. 1999 Apr;13(2):311-32. Review.

PMID:
10363133
25.

Breast cancer biology blossoms in the clinic.

Nass SJ, Hahm HA, Davidson NE.

Nat Med. 1998 Jul;4(7):761-2. No abstract available.

PMID:
9662357
26.

Mapping of ER gene CpG island methylation-specific polymerase chain reaction.

Lapidus RG, Nass SJ, Butash KA, Parl FF, Weitzman SA, Graff JG, Herman JG, Davidson NE.

Cancer Res. 1998 Jun 15;58(12):2515-9.

27.

Defining a role for c-Myc in breast tumorigenesis.

Nass SJ, Dickson RB.

Breast Cancer Res Treat. 1997 May;44(1):1-22. Review.

PMID:
9164674
28.

Role for Bcl-xL in the regulation of apoptosis by EGF and TGF beta 1 in c-myc overexpressing mammary epithelial cells.

Nass SJ, Li M, Amundadottir LT, Furth PA, Dickson RB.

Biochem Biophys Res Commun. 1996 Oct 3;227(1):248-56.

PMID:
8858133
29.

Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.

Amundadottir LT, Nass SJ, Berchem GJ, Johnson MD, Dickson RB.

Oncogene. 1996 Aug 15;13(4):757-65.

PMID:
8761297
30.
31.

Drug screening.

Nass SJ.

J Athl Train. 1994 Sep;29(3):197. No abstract available.

32.

The genetic map around the tail kinks (tk) locus on mouse chromosome 9.

Imai K, Nass SJ, Olowson M, Balling R.

Mamm Genome. 1993;4(10):560-4.

PMID:
8268653
33.

Mapping of the Mod-1 locus on mouse chromosome 9.

Nass SJ, Olowson M, Miyashita N, Moriwaki K, Balling R, Imai K.

Mamm Genome. 1993;4(6):333-7.

PMID:
8100460
34.
35.

Supplemental Content

Support Center